TipRanks
HCA Healthcare (CH:2BH)
:2BH
Switzerland Market
2BH
HCA Healthcare
RESEARCH TOOLSreports

HCA Healthcare (2BH) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

2BH Analyst Ratings

Moderate Buy
22Ratings
Moderate Buy
14 Buy
7 Hold
1 Sell
Based on 22 analysts giving stock ratings to
HCA
Healthcare
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

2BH Stock 12 Month Forecast

Average Price Target

CHF376.62
▲(14.59% Upside)
Based on 22 Wall Street analysts offering 12 month price targets for HCA Healthcare in the last 3 months. The average price target is CHF376.62 with a high forecast of CHF480.15 and a low forecast of CHF315.12. The average price target represents a 14.59% change from the last price of CHF328.66.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"314":"CHF314","481":"CHF481","355.75":"CHF355.8","397.5":"CHF397.5","439.25":"CHF439.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":480.15006288,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF480.15</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":376.6151140880001,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF376.62</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":315.1243936,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF315.12</span>\n  </div></div>","useHTML":true}}],"tickPositions":[314,355.75,397.5,439.25,481],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,330.393,341.9127740676923,353.4325481353846,364.9523222030769,376.4720962707692,387.9918703384615,399.51164440615383,411.03141847384614,422.55119254153846,434.07096660923077,445.5907406769231,457.1105147446154,468.6302888123077,{"y":480.15006288,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,330.393,333.94854723753843,337.5040944750769,341.05964171261536,344.6151889501539,348.17073618769234,351.7262834252308,355.28183066276927,358.83737790030773,362.3929251378462,365.94847237538465,369.5040196129232,373.05956685046164,{"y":376.6151140880001,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,330.393,329.2184918153846,328.0439836307692,326.86947544615384,325.69496726153847,324.5204590769231,323.3459508923077,322.1714427076923,320.9969345230769,319.8224263384615,318.64791815384615,317.4734099692308,316.2989017846154,{"y":315.1243936,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":330.701,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":330.701,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":330.701,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":330.701,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":330.701,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":330.701,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":330.701,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":330.701,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":330.701,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":330.701,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":330.701,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":322.643,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":330.393,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetCHF480.15Average Price TargetCHF376.62Lowest Price TargetCHF315.12
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Raymond James Analyst forecast on CH:2BH
Andrew Cooper
Raymond James
Raymond James
―
Hold
―
Reiterated
09/28/26
Analysts Offer Insights on NA Companies: HCA Healthcare (NYSE: HCA), Grupo Televisa, S.A.B. (NYSE: TV) and Pasqal Holding SA (NASDAQ: PSQL)
BMO Capital Analyst forecast on CH:2BH
Sean Dodge
BMO Capital
BMO Capital
CHF410.49
Buy
24.90%
Upside
Initiated
09/22/26
HCA Healthcare initiated with an Outperform at BMO CapitalHCA Healthcare initiated with an Outperform at BMO Capital
Jefferies Analyst forecast on CH:2BH
Brian Tanquilut
Jefferies
Jefferies
CHF373.17
Buy
13.54%
Upside
Reiterated
09/17/26
Jefferies Sticks to Its Buy Rating for HCA Healthcare (HCA)
Leerink Partners Analyst forecast on CH:2BH
Whit Mayo
Leerink Partners
Leerink Partners
―
Buy
―
Reiterated
09/17/26
Analysts Offer Insights on NA Companies: Douglas AG (Other OTC: DOUDF) and HCA Healthcare (NYSE: HCA)
Bernstein Analyst forecast on CH:2BH
Lance Wilkes
Bernstein
Bernstein
CHF353.27
Hold
7.49%
Upside
Reiterated
09/09/26
Bernstein Keeps Their Hold Rating on HCA Healthcare (HCA)
RBC Capital Analyst forecast on CH:2BH
Ben Hendrix
RBC Capital
RBC Capital
CHF360.73
Buy
9.76%
Upside
Reiterated
09/07/26
Analysts Offer Insights on NA Companies: HCA Healthcare (NYSE: HCA) and Reformation, Inc. (NYSE: REF)
J.P. Morgan Analyst forecast on CH:2BH
Benjamin Rossi
J.P. Morgan
J.P. Morgan
CHF352.44
Hold
7.24%
Upside
Reiterated
08/24/26
J.P. Morgan Reaffirms Their Hold Rating on HCA Healthcare (HCA)
Bank of America Securities Analyst forecast on CH:2BH
Kevin Fischbeck
Bank of America Securities
Bank of America Securities
CHF331.71→CHF352.44
Hold
7.24%
Upside
Reiterated
08/10/26
HCA Healthcare (HCA) Receives a Hold from Bank of America Securities
Argus Research Analyst forecast on CH:2BH
David Toung
Argus Research
Argus Research
CHF414.64
Buy
26.16%
Upside
Assigned
08/07/26
Argus Research Sticks to Its Buy Rating for HCA Healthcare (HCA)
Truist Financial Analyst forecast on CH:2BH
David S Macdonald
Truist Financial
Truist Financial
CHF410.49
Buy
24.90%
Upside
Reiterated
08/05/26
Truist Financial Sticks to Its Buy Rating for HCA Healthcare (HCA)
Wells Fargo Analyst forecast on CH:2BH
Stephen Baxter
Wells Fargo
Wells Fargo
CHF306→CHF315.95
Hold
-3.87%
Downside
Assigned
08/03/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: AptarGroup (NYSE: ATR), Myriad Genetics (NASDAQ: MYGN) and HCA Healthcare (NYSE: HCA)
Mizuho Securities Analyst forecast on CH:2BH
Ann Hynes
Mizuho Securities
Mizuho Securities
CHF435.37→CHF393.91
Buy
19.85%
Upside
Reiterated
07/28/26
HCA Healthcare price target lowered to $475 from $525 at MizuhoHCA Healthcare price target lowered to $475 from $525 at Mizuho
Oppenheimer Analyst forecast on CH:2BH
Michael Wiederhorn
Oppenheimer
Oppenheimer
CHF431.22→CHF402.2
Buy
22.38%
Upside
Reiterated
07/27/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
UBS Analyst forecast on CH:2BH
A.J. Rice
UBS
UBS
CHF526.59→CHF480.15
Buy
46.09%
Upside
Reiterated
07/27/26
HCA Healthcare price target lowered to $579 from $635 at UBSHCA Healthcare price target lowered to $579 from $635 at UBS
Morgan Stanley Analyst forecast on CH:2BH
Craig Hettenbach
Morgan Stanley
Morgan Stanley
CHF352.44→CHF315.12
Sell
-4.12%
Downside
Reiterated
07/27/26
HCA Healthcare price target lowered to $380 from $425 at Morgan StanleyHCA Healthcare price target lowered to $380 from $425 at Morgan Stanley
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Raymond James Analyst forecast on CH:2BH
Andrew Cooper
Raymond James
Raymond James
―
Hold
―
Reiterated
09/28/26
Analysts Offer Insights on NA Companies: HCA Healthcare (NYSE: HCA), Grupo Televisa, S.A.B. (NYSE: TV) and Pasqal Holding SA (NASDAQ: PSQL)
BMO Capital Analyst forecast on CH:2BH
Sean Dodge
BMO Capital
BMO Capital
CHF410.49
Buy
24.90%
Upside
Initiated
09/22/26
HCA Healthcare initiated with an Outperform at BMO CapitalHCA Healthcare initiated with an Outperform at BMO Capital
Jefferies Analyst forecast on CH:2BH
Brian Tanquilut
Jefferies
Jefferies
CHF373.17
Buy
13.54%
Upside
Reiterated
09/17/26
Jefferies Sticks to Its Buy Rating for HCA Healthcare (HCA)
Leerink Partners Analyst forecast on CH:2BH
Whit Mayo
Leerink Partners
Leerink Partners
―
Buy
―
Reiterated
09/17/26
Analysts Offer Insights on NA Companies: Douglas AG (Other OTC: DOUDF) and HCA Healthcare (NYSE: HCA)
Bernstein Analyst forecast on CH:2BH
Lance Wilkes
Bernstein
Bernstein
CHF353.27
Hold
7.49%
Upside
Reiterated
09/09/26
Bernstein Keeps Their Hold Rating on HCA Healthcare (HCA)
RBC Capital Analyst forecast on CH:2BH
Ben Hendrix
RBC Capital
RBC Capital
CHF360.73
Buy
9.76%
Upside
Reiterated
09/07/26
Analysts Offer Insights on NA Companies: HCA Healthcare (NYSE: HCA) and Reformation, Inc. (NYSE: REF)
J.P. Morgan Analyst forecast on CH:2BH
Benjamin Rossi
J.P. Morgan
J.P. Morgan
CHF352.44
Hold
7.24%
Upside
Reiterated
08/24/26
J.P. Morgan Reaffirms Their Hold Rating on HCA Healthcare (HCA)
Bank of America Securities Analyst forecast on CH:2BH
Kevin Fischbeck
Bank of America Securities
Bank of America Securities
CHF331.71→CHF352.44
Hold
7.24%
Upside
Reiterated
08/10/26
HCA Healthcare (HCA) Receives a Hold from Bank of America Securities
Argus Research Analyst forecast on CH:2BH
David Toung
Argus Research
Argus Research
CHF414.64
Buy
26.16%
Upside
Assigned
08/07/26
Argus Research Sticks to Its Buy Rating for HCA Healthcare (HCA)
Truist Financial Analyst forecast on CH:2BH
David S Macdonald
Truist Financial
Truist Financial
CHF410.49
Buy
24.90%
Upside
Reiterated
08/05/26
Truist Financial Sticks to Its Buy Rating for HCA Healthcare (HCA)
Wells Fargo Analyst forecast on CH:2BH
Stephen Baxter
Wells Fargo
Wells Fargo
CHF306→CHF315.95
Hold
-3.87%
Downside
Assigned
08/03/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: AptarGroup (NYSE: ATR), Myriad Genetics (NASDAQ: MYGN) and HCA Healthcare (NYSE: HCA)
Mizuho Securities Analyst forecast on CH:2BH
Ann Hynes
Mizuho Securities
Mizuho Securities
CHF435.37→CHF393.91
Buy
19.85%
Upside
Reiterated
07/28/26
HCA Healthcare price target lowered to $475 from $525 at MizuhoHCA Healthcare price target lowered to $475 from $525 at Mizuho
Oppenheimer Analyst forecast on CH:2BH
Michael Wiederhorn
Oppenheimer
Oppenheimer
CHF431.22→CHF402.2
Buy
22.38%
Upside
Reiterated
07/27/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
UBS Analyst forecast on CH:2BH
A.J. Rice
UBS
UBS
CHF526.59→CHF480.15
Buy
46.09%
Upside
Reiterated
07/27/26
HCA Healthcare price target lowered to $579 from $635 at UBSHCA Healthcare price target lowered to $579 from $635 at UBS
Morgan Stanley Analyst forecast on CH:2BH
Craig Hettenbach
Morgan Stanley
Morgan Stanley
CHF352.44→CHF315.12
Sell
-4.12%
Downside
Reiterated
07/27/26
HCA Healthcare price target lowered to $380 from $425 at Morgan StanleyHCA Healthcare price target lowered to $380 from $425 at Morgan Stanley
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering HCA Healthcare

3 Months
Sarah JamesCantor Fitzgerald
Success Rate
15/19 ratings generated profit
79%
Average Return
+8.12%
Copying Sarah James's trades and holding each position for 3 Months would result in 78.95% of your transactions generating a profit, with an average return of +8.12% per trade.
1 Year
Sarah JamesCantor Fitzgerald
Success Rate
18/19 ratings generated profit
95%
Average Return
+19.83%
Copying Sarah James's trades and holding each position for 1 Year would result in 94.74% of your transactions generating a profit, with an average return of +19.83% per trade.
2 Years
Whit MayoLeerink Partners
Success Rate
47/47 ratings generated profit
100%
Average Return
+51.38%
Copying Whit Mayo's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +51.38% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

2BH Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
0
0
1
1
1
Buy
15
16
25
25
26
Hold
9
11
15
19
19
Sell
0
0
2
2
2
Strong Sell
0
0
0
0
0
total
24
27
43
47
48
In the current month, 2BH has received 27 Buy Ratings, 19 Hold Ratings, and 2 Sell Ratings. 2BH average Analyst price target in the past 3 months is 376.62.
Each month's total comprises the sum of three months' worth of ratings.

2BH Financial Forecast

2BH Earnings Forecast

Next quarter’s earnings estimate for 2BH is CHF5.54 with a range of CHF4.83 to CHF6.10. The previous quarter’s EPS was CHF6.29. 2BH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year 2BH has Performed in-line its overall industry.
Next quarter’s earnings estimate for 2BH is CHF5.54 with a range of CHF4.83 to CHF6.10. The previous quarter’s EPS was CHF6.29. 2BH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year 2BH has Performed in-line its overall industry.

2BH Sales Forecast

Next quarter’s sales forecast for 2BH is CHF16.04B with a range of CHF15.59B to CHF16.48B. The previous quarter’s sales results were CHF16.78B. 2BH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year 2BH has Performed in-line its overall industry.
Next quarter’s sales forecast for 2BH is CHF16.04B with a range of CHF15.59B to CHF16.48B. The previous quarter’s sales results were CHF16.78B. 2BH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year 2BH has Performed in-line its overall industry.

2BH Stock Forecast FAQ

What is CH:2BH’s average 12-month price target, according to analysts?
Based on analyst ratings, HCA Healthcare’s 12-month average price target is 376.62.
    What is CH:2BH’s upside potential, based on the analysts’ average price target?
    HCA Healthcare has 14.59% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is HCA Healthcare a Buy, Sell or Hold?
          HCA Healthcare has a consensus rating of Moderate Buy, which is based on 14 buy ratings, 7 hold ratings and 1 sell ratings.
            What is HCA Healthcare’s share price target?
            The average share price target for HCA Healthcare is 376.62. This is based on 22 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is CHF480.15 ,and the lowest forecast is CHF315.12. The average share price target represents 14.59% Increase from the current price of CHF328.66.
              What do analysts say about HCA Healthcare?
              HCA Healthcare’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 22 Wall Streets Analysts.
                How can I buy shares of HCA Healthcare?
                To buy shares of CH:2BH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.